These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Structure, physiological role, and specific inhibitors of human thymidine kinase 2 (TK2): present and future. Pérez-Pérez MJ, Priego EM, Hernández AI, Familiar O, Camarasa MJ, Negri A, Gago F, Balzarini J. Med Res Rev; 2008 Sep; 28(5):797-820. PubMed ID: 18459168 [Abstract] [Full Text] [Related]
23. Retained sensitivity to cytotoxic pyrimidine nucleoside analogs in thymidine kinase 2 deficient human fibroblasts. Bjerke M, Solaroli N, Lesko N, Balzarini J, Johansson M, Karlsson A. Nucleosides Nucleotides Nucleic Acids; 2010 Jan; 29(1):1-13. PubMed ID: 20391188 [Abstract] [Full Text] [Related]
24. Synthesis and biological evaluation of 3'-carboranyl thymidine analogues. Yan J, Naeslund C, Al-Madhoun AS, Wang J, Ji W, Cosquer GY, Johnsamuel J, Sjöberg S, Eriksson S, Tjarks W. Bioorg Med Chem Lett; 2002 Aug 19; 12(16):2209-12. PubMed ID: 12127539 [Abstract] [Full Text] [Related]
26. Mutagenesis of non-conserved active site residues improves the activity and narrows the specificity of human thymidine kinase 2. Gerth ML, Lutz S. Biochem Biophys Res Commun; 2007 Mar 16; 354(3):802-7. PubMed ID: 17266931 [Abstract] [Full Text] [Related]
27. The role of thymidine kinases in the activation of pyrimidine nucleoside analogues. Al-Madhoun AS, Tjarks W, Eriksson S. Mini Rev Med Chem; 2004 May 16; 4(4):341-50. PubMed ID: 15134537 [Abstract] [Full Text] [Related]
32. The design, synthesis and properties of highly potent and selective inhibitors of herpes simplex virus types 1 and 2 thymidine kinase. Martin JA, Thomas GJ, Merrett JH, Lambert RW, Bushnell DJ, Dunsdon SJ, Freeman AC, Hopkins RA, Johns IR, Keech E, Simmonite H, Kai-In PW, Holland M. Antivir Chem Chemother; 1998 Jan 16; 9(1):1-8. PubMed ID: 9875371 [Abstract] [Full Text] [Related]
34. Synthesis of ethyleneoxide modified 3-carboranyl thymidine analogues and evaluation of their biochemical, physicochemical, and structural properties. Johnsamuel J, Lakhi N, Al-Madhoun AS, Byun Y, Yan J, Eriksson S, Tjarks W. Bioorg Med Chem; 2004 Sep 15; 12(18):4769-81. PubMed ID: 15336255 [Abstract] [Full Text] [Related]
36. Discovery of bicyclic thymidine analogues as selective and high-affinity inhibitors of Mycobacterium tuberculosis thymidine monophosphate kinase. Vanheusden V, Munier-Lehmann H, Froeyen M, Busson R, Rozenski J, Herdewijn P, Van Calenbergh S. J Med Chem; 2004 Dec 02; 47(25):6187-94. PubMed ID: 15566289 [Abstract] [Full Text] [Related]
37. 3'-C-branched-chain-substituted nucleosides and nucleotides as potent inhibitors of Mycobacterium tuberculosis thymidine monophosphate kinase. Vanheusden V, Munier-Lehmann H, Froeyen M, Dugué L, Heyerick A, De Keukeleire D, Pochet S, Busson R, Herdewijn P, Van Calenbergh S. J Med Chem; 2003 Aug 28; 46(18):3811-21. PubMed ID: 12930144 [Abstract] [Full Text] [Related]
38. Differential affinities of pyrimidine nucleoside analogues for deoxythymidine and deoxycytidine kinase determine their incorporation into murine leukemia L1210 cells. Balzarini J, De Clercq E. Acta Biochim Pol; 1987 Aug 28; 34(2):63-77. PubMed ID: 2823514 [Abstract] [Full Text] [Related]
40. The synthesis and biochemical evaluation of thymidine analogues substituted with nido carborane at the N-3 position. Byun Y, Yan J, Al-Madhoun AS, Johnsamuel J, Yang W, Barth RF, Eriksson S, Tjarks W. Appl Radiat Isot; 2004 Nov 28; 61(5):1125-30. PubMed ID: 15308203 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]